Articles

The TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits

The Federal Court granted the interim injunction on 3 April 2020

The TGA has issued ATP Science Pty Ltd with 24 infringement notices

The TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches

The TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19

The Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia (Court) against Evolution Supplements Australia Pty Ltd

Caruso's Natural Health pays $12,600 fine for false certification in relation to therapeutic good

Juice Plus Company Australia Pty Ltd has paid penalties of $37,800 for alleged advertising breaches relating to vitamin products

InSkin Cosmedics Group Pty Ltd has paid penalties of $37,800 in regards to the alleged supply and advertising of the Dermapen 4

Pharmacies and others can advertise availability of OTC salbutamol products during the bushfire season

On 20 November 2019 the TGA issued a direction notice to Cat Media concerning its advertising of Fatblaster Clinical

Mundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA

Consumer Healthcare Products Australia to handle all medicine advertising pre-approval applications

The Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications

The Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne

Changes are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements

The TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices

Direction Notice issued to cease advertising of therapeutic goods not entered in the ARTG

Direction Notice issued to cease advertising of unregistered therapeutic goods to consumers

The Federal Court has imposed substantial penalties on Peptide Clinics Australia

Reasons for releasing guidance and how it was developed

Court action continues against Peptide Clinics Australia for alleged advertising breaches

Do your research before consenting to live blood analysis, electrodermal testing and other related tests

This update implements feedback from stakeholders to make the database more user-friendly

Direction Notice issued to cease advertisement of prescription and illegal products